GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » PEG Ratio

Pulike Biological Engineering (SHSE:603566) PEG Ratio : 5.25 (As of May. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Pulike Biological Engineering's PE Ratio without NRI is 44.61. Pulike Biological Engineering's 5-Year EBITDA growth rate is 8.50%. Therefore, Pulike Biological Engineering's PEG Ratio for today is 5.25.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Pulike Biological Engineering's PEG Ratio or its related term are showing as below:

SHSE:603566' s PEG Ratio Range Over the Past 10 Years
Min: 1.09   Med: 2.3   Max: 14.45
Current: 5.25


During the past 13 years, Pulike Biological Engineering's highest PEG Ratio was 14.45. The lowest was 1.09. And the median was 2.30.


SHSE:603566's PEG Ratio is ranked worse than
82.88% of 111 companies
in the Biotechnology industry
Industry Median: 1.49 vs SHSE:603566: 5.25

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Pulike Biological Engineering PEG Ratio Historical Data

The historical data trend for Pulike Biological Engineering's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulike Biological Engineering PEG Ratio Chart

Pulike Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 20.37 1.81 2.65 4.89

Pulike Biological Engineering Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.46 2.47 2.34 4.89 5.56

Competitive Comparison of Pulike Biological Engineering's PEG Ratio

For the Biotechnology subindustry, Pulike Biological Engineering's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulike Biological Engineering's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's PEG Ratio falls into.



Pulike Biological Engineering PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Pulike Biological Engineering's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=44.612068965517/8.50
=5.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Pulike Biological Engineering  (SHSE:603566) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Pulike Biological Engineering PEG Ratio Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering (SHSE:603566) Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Hu Wei Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering (SHSE:603566) Headlines

No Headlines